Botanical species · safety record

Gomphrena globosa

The EFSA Compendium of Botanicals holds 4 constituent measurements for Gomphrena globosa. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Gomphrena globosa L.

4Constituent measurements

0Safety records

2Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Leaves	Solvent extraction	0.46 Percent	Phytochemical screening	No resolvable identifier
Indole alkaloids	Flowering top	Solvent extraction	≥ 3.5 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Indole alkaloids	Flowering top	Solvent extraction	≤ 40 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Saponins	Leaves	Solvent extraction	0.29 Percent	Phytochemical screening	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Cai, YZ., Sun, M., Corke, H. Identification and distribution of simple and acylated betacyanins in the amaranthaceae. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2001, vol. 49, no. 4, p. 1971-1978.
Omodamiro, O.D., Jimoh, M.A. Hypoglycemic effect of ethanolic leaves extracts of Anacardium occidentalis and Gomphrena globosa plants on alloxan induced-diabetic rats. Journal of Chemical and Pharmaceutical Research, 2014, vol. 6, no. 1, p. 492-498.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature